C-reactive protein serum levels as an early predictor of outcome in patients with pandemic H1N1 influenza A virus infection by Zimmerman, Ofer et al.
RESEARCH ARTICLE Open Access
C-reactive protein serum levels as an early
predictor of outcome in patients with pandemic
H1N1 influenza A virus infection
Ofer Zimmerman
1*†, Ori Rogowski
1†, Galit Aviram
2, Michal Mizrahi
1, David Zeltser
1, Dan Justo
3, Esther Dahan
4,
Roy Arad
1, Oholi Touvia
1, Luba Tau
1, Jalal Tarabeia
5, Shlomo Berliner
1, Yael Paran
6
Abstract
Background: Data for predicting which patients with pandemic influenza A (H1N1) infection are likely to run a
complicated course are sparse. We retrospectively studied whether the admission serum C-reactive protein (CRP)
levels can serve as a predictor of illness severity.
Methods: Included were all consecutive adult patients who presented to the emergency department (ED)
between May-December, 2009 with a flu-like illness, a confirmed diagnosis of pandemic influenza A (H1N1)
infection and a serum CRP level measured within 24 hours of presentation. Patients with a proven additional
concurrent acute illness (e.g., bacteremia) were excluded. We used the ROC curve analysis, Kaplan-Meier curves and
the Cox proportional hazard model to evaluate the predictive ability of CRP as a prognostic factor.
Results: Seventeen (9%) of the 191 enrolled patients were admitted to the intensive care unit (ICU), of whom
eight (4%) required mechanical ventilation and three (2%) died. The median admission serum CRP levels were
significantly higher among patients who required subsequent ICU care and mechanical ventilation than among
patients who did not (123 mg/L and 112 mg/L vs. 40 mg/L, p < .001 and 43 mg/L, p = .017, respectively). A Cox
proportional hazard model identified admission serum CRP levels and auscultatory findings over the lungs as
independent prognostic factors for ICU admission. Admission serum CRP levels were the only independent
prognostic factor for mechanical ventilation. Thirty days after presenting to the ED, none of the patients with
admission serum CRP level <28 mg/L (lower tertile) required either ICU admission or mechanical ventilation. At the
same time point, 19% of the patients with admission serum CRP level ≥70 mg/L (upper tertile) needed to be
admitted to the ICU and 8% of the same upper tertile group required mechanical ventilation. The differences in
the rates between the lower vs. upper tertile groups were significant (Log-Rank p < .001 for ICU and p < .024 for
mechanical ventilation).
Conclusions: In our study group, serum CRP levels obtained in the early ED admission stage from patients
presenting with pandemic H1N1 influenza A infection were found to serve as a useful gauge for predicting disease
course and assisting in patient management.
Background
The clinical manifestations of pandemic H1N1 influenza
A infection range from a relatively mild and self-limiting
respiratory infection to a severe illness with significant
morbidity and mortality [1,2]. There is no single
laboratory test that can serve as a potential biomarker
to identify the patients at high risk for a complicated
clinical course. Shortly after the pandemic reached our
catchment area, we noted that some of the patients who
needed to be hospitalized for severe H1N1 infection had
high serum levels of C-reactive protein (CRP), which are
usually seen in systemic bacterial infections and not in
viral respiratory diseases [3-6]. High serum CRP levels
were found in patients affected by Corona virus during
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in 2002 [7,8], when they were also identified as predic-
tors of respiratory failure and death [7-9].
The current retrospective study examined serum CRP
levels obtained during the first 24 hours since admission
to emergency department (ED) as a predictor of illness
severity among patients infected with the 2009 pan-
demic influenza A (H1N1). The evaluation compared
the predictive capacity of serum CRP levels with that of
other factors, such as underlying medical conditions,
vital signs, physical signs, chest radiograph findings and
laboratory test results.
Methods
Participants
The study was approved by the local ethics committee
of the Tel Aviv Sourasky Medical Center, and informed
patient consent was waived due to the observational
nature of the study. The setting for this investigation
was a single tertiary care university-affiliated medical
center. The Tel Aviv Sourasky Medical Center serves a
population of 1 million citizens in the Tel Aviv munici-
pal area. All of the patients were 18 years of age or
older. Data were collected for all consecutive patients
admitted to the ED between May 1 and December 31,
2009, who fulfilled the clinical criteria for confirmed
H1N1 influenza infection as established by the United
States Centers for Disease Control and Prevention
(CDC). These criteria included flu-like symptoms, such
as a body temperature of 37.8°C (100°F) or higher,
cough or sore throat, and a real-time reverse transcrip-
tase polymerase chain reaction assay (RT-PCR) positive
for H1N1 virus [10]. All patients whose serum CRP
levels were measured within 24 hours of presentation to
the ED were eligible for inclusion, whether they were
subsequently hospitalized or discharged after initial eva-
luation. Following a review of patients’ charts and
records for symptoms and signs, laboratory and imaging
findings, and blood and urine cultures (when available),
patients with a proven additional concurrent acute ill-
ness (e.g., bacteremia) were excluded from the study.
Study Design
Patients’ records were reviewed for demographics, back-
ground diseases (including obesity, diabetes, current
smoking, asthma, chronic obstructive pulmonary disease
(COPD), ischemic heart disease (IHD), congestive heart
failure (CHF), and active cancer), pregnancy, permanent
steroid therapy, current chemotherapy, physical signs,
vital signs, laboratory findings, chest radiograph findings,
length of hospitalization, admission to the intensive care
unit (ICU), need for mechanical ventilation, and death.
The following times were also noted: from the first symp-
tom to admission, from admission to ICU, provision of
mechanical ventilation, and death. Radiologists unaware
of patients’ clinical data and outcome reviewed all chest
radiographs obtained within 24 hours of admission to the
ED, for findings characteristic of H1N1 pneumonia in
adults, according to recently published descriptions
[11,12]. The main outcome measures were whether or
not the patient was admitted to the ICU, if mechanical
ventilation was required and death. Follow-up of all the
enrolled patients was managed via a telephone survey
conducted at least 30 days since hospital admission. The
query items focused on the appearance of any additional
symptoms, the administration of any additional medical
treatment, re-hospitalization, and outcome.
Statistical Analysis
Values are presented as means ± SD or median and
interquartile range (IQR) for the continuous variables
and as number of individuals (and the percentage in
each group) for the categorical variables. The compari-
son of continuous variables between groups was by
independent samples Student’st - t e s tf o rn o r m a l l yd i s -
tributed variables and by the Mann-Whitney U statistics
for non-normally distributed variables. Frequencies of
categorical variables were compared by the Fisher exact
test. In order to assess CRP as an early predictor of out-
come, a receiver operating characteristic (ROC) curve
was plotted and the area under the curve was calculated
to determine the predictive ability of different CRP
serum level cutoff values for the different outcomes
[13]. Primary outcomes of required transfer to ICU and
mechanical ventilation were evaluated on a time-to-
event basis by Kaplan-Meier analysis with the use of the
log-rank statistics to test for determining differences in
the rates of the end points according to serum CRP
levels. Cox proportional-hazard modeling was used,
applying the forward stepwise analysis method to assess
the effects of potential outcome markers. The SPSS sta-
tistical package was used to perform all the statistical
evaluations (SSPS Inc., Chicago, IL, USA). For all ana-
lyses, a value of p < .05 (two-tailed) was considered to
indicate statistical significance.
Results
During the study period, 315 adult patients who fulfilled
the CDC clinical criteria forc o n f i r m e dH 1 N 1i n f l u e n z a
virus infection [10] were admitted to the ED. In 209 of
these patients (66%), serum CRP levels were measured
within 24 hours of admission. Blood and urine cultures
were obtained on admission in 110 (53%) and in 65
(31%) of these 209 patients, respectively. Eighteen
patients (9%) were excluded from this study due to a
concurrent acute illness on presentation. Consequently,
the final study cohort comprised 191 patients whose
serum CRP levels were obtained within 24 hours of
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Page 2 of 8admission and whose sole acute illness was a confirmed
diagnosis of H1N1 influenza-virus infection. Patients’
mean age was 43 ± 16 years (range 18-85). There were
95 (50%) female and 96 (50%) male patients. The most
common background medical conditions were active
smoking (n = 50, 26%), asthma (n = 37, 19%), diabetes
mellitus (n = 24, 13%) and COPD (n = 22, 12%).
The median time from symptom onset until presenta-
tion to the ED was 72 hours (IQR 48-120). The median
time from admission until first serum CRP level deter-
mination was 1 hour and 17 minutes. One hundred
sixty eight (88%) patients were hospitalized and 23
(12%) were discharged to their homes after the initial
evaluation in the ED. The median length of hospitaliza-
tion was 3 days [2-5].
Seventeen (9%) patients were admitted to the ICU, of
whom eight (4%) required mechanical ventilation and
three died (2%). All 185 (98%) of the 188 surviving
patients contacted through a follow-up telephone survey
described an unremarkable clinical course of the disease
in the thirty days since they presented at the ED.
With the exception of one patient who was transferred
directly from the ED to the ICU, all of the admitted
patients were first transferred from the ED to a hospital
ward. Sixteen patients were subsequently transferred to
the ICU. The median time from admission to the ED to
transfer to the ICU was 53 hours (IQR 23-65). There
was no significant difference in the prevalence of back-
ground medical conditions among the patients who
required hospitalization in the ICU and those who did
not (data not shown). The median time between the
onset of first symptoms until presentation to the ED
was similar for both hospitalized groups (Table 1).
Low blood oxygen saturation (≤90%) on presentation to
the ED and abnormal auscultatory findings over the lung
fields (bronchial breath sounds or crackles) on admission
were more common in the patients who were eventually
admitted to ICU compared to those who remained in the
wards (Table 1). The same clinical observation was noted
in regard to patients who required mechanical ventilation
compared to those who did not; however, in this compari-
son, the difference was not statistically significant (data
not shown). Seventy-four of the 177 (93%) patients who
underwent chest radiography within 24 hours of admis-
sion had findings consistent with pneumonia. The preva-
lence of these findings was significantly higher among the
patients who required ICU care compared with those who
did not (Table 1). Chest radiographic findings consistent
with pneumonia were also more prevalent among patients
who required mechanical ventilation than among those
who did not, but this difference was not significant (6/8
(75%) vs. 68/170 (40%), respectively, p = .069).
Among the evaluated laboratory parameters, serum
CRP levels and neutrophil percentage in a complete
blood count (CBC) obtained within 24 hours of admis-
sion comprised the only two factors that significantly
differentiated between patients who needed to be
admitted to the ICU and those who could remain on
the ward (Table 1). Unfortunately, we could not include
the parameter of patients’ blood gases in the current
analysis, since such a sample was obtained from only a
few of the patients.
Serum CRP levels were the only laboratory parameter
that significantly differentiated between patients who
required mechanical ventilation and those who did not
(112 mg/L [IQR 45-180] vs. 43 mg/L [IQR 22-89],
respectively, p = .017). Figures 1 and 2 display box-plots
of serum CRP levels, according to ICU admission and
need for mechanical ventilation, respectively.
The ability to consider serum CRP levels obtained
during the first 24 hours of ED admission as a biomar-
ker for predicting pandemic H1N1 influenza A patients’
need for ICU care or mechanical ventilation was evalu-
ated using ROC curve analysis. The small number of
deaths in our cohort precluded the performing of ROC
curve analysis for that outcome. The area under the
curve (AUC) for ICU admission was 0.82 (95% CI =
0.73-0.91; p < .001). The AUC for mechanical ventila-
tion was 0.75 (95% CI = 0.60-0.90; p = .017). The sensi-
tivity, specificity and positive and negative predictive
values (PPV and NPV) for ICU admission and mechani-
cal ventilation of serum CRP at different cut-off levels
are displayed in Table 2.
The Cox proportional hazard model was applied to
assess the ability of the following factors to predict the
need for ICU admission: low oxygen saturation (≤90%),
abnormal auscultatory findings over lung fields, chest
radiograph findings consistent with pneumonia, percen-
tage of neutrophil in a CBC, and serum CRP levels. The
first variable that entered the model was CRP (p = .001),
followed by abnormal auscultatory findings (p = .028).
None of the other three variables entered the model
afterwards. The CRP hazard ratio (95% confidence inter-
val [CI]) for transfer to the ICU was 1.09 (1.06-1.12) for
each increase of 10 mg/L in CRP level. The hazard ratio
( 9 5 %C I )o fp r e s e n c eo fa u s c u l t a t o r yf i n d i n g so v e rt h e
lung fields for being transferred to the ICU was 3.85
(1.16-12.8).
The Cox proportional hazard model was applied to
assess the ability of serum CRP level to predict the need
for mechanical ventilation. The CRP level was the only
variable that entered the model (p = .018), and the hazard
ratio (95% CI) for mechanical ventilation was 1.09 (1.05 -
1.13) for each increase of 10 mg/L in CRP level.
A Kaplan-Meier estimate of the two main outcome
measures, i.e., the need for ICU admission and for
mechanical ventilation, was performed using tertiles of
serum CRP levels (i.e., <28, 28-69, and ≥70 mg/L).
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ED, none of the patients with a serum CRP level <28
mg/L (lower tertile) needed to be admitted to the ICU
or required mechanical ventilation (Figures 3 and 4). At
t h es a m et i m ep o i n t ,1 9 %o ft h ep a t i e n t sw i t has e r u m
CRP level ≥70 mg/L (upper tertile) needed to be
admitted to the ICU and 8% required mechanical venti-
lation. The differences in the rates between the lower vs.
upper tertile groups were significant (Log-Rank p <. 0 0 1
for ICU and p < .024 for mechanical ventilation).
Discussion
The results of the study confirm that low saturation
(< 90%), auscultatory findings over the lung fields, find-
ings consistent with pneumonia on chest radiography,
high percentage of neutrophil in a CBC and high serum
CRP levels at the time of presentation to the ED are
associated with a severe course of H1N1 influenza A
virus infection. Of these variables, serum CRP levels
were found to be the best predictor of subsequent need
for ICU admission and the only predictor of subsequent
need for mechanical ventilation.
Moreover, low initial serum CRP levels were an excel-
lent predictor of good outcome: at 30 days from admis-
sion, none of the patients with CRP levels lower than 33
mg/L required either ICU care or mechanical ventilation.
The fact that patients with low serum CRP levels enjoyed
good outcome may serve as a guiding tool, enabling the
assessing clinician in the ED to differentiate between
“low risk” patients vs. “high risk” patients. As evident
from Table 2, a cut-off value of 33 mg/L is a viable choice
that achieves 100% sensitivity but a specificity of only
around 40% for ICU admission or mechanical ventilation.
By comparison, a slightly higher CRP cut-off of 64 mg/L
achieved lower but acceptable sensitivities of 82% and
75% for ICU admission and mechanical ventilation,
respectively, with higher specificities of 68% and 65%,
respectively. Thus, it appears that serum CRP levels may
have a significant role in helping the physician in the
decision making process on the individual patient level.
Table 1 Comparison between variables of ICU and non-ICU patients
Variable ICU
(n = 17)
Non-ICU
(n = 174)
p value
Time to ED (hours), median (IQR)* 96 (24 – 168) 72 (48 – 120) 0.506
Sys BP (mmHg), median (IQR) 128 (104 – 148) 125 (114 – 140) 0.904
Hypotension (sys BP < 90 mmHg), n (%) 0 (0) 4 (2.5) >0.999
Dias BP (mmHg), median (IQR) 80 (62 – 95) 77 (69 – 84) 0.619
Heart rate (beats/min), median (IQR) 100 (81 – 118) 96 (86 – 108) 0.640
Tachycardia (>100 beats/min), n (%) 8 (47) 61 (38) 0.601
Fever (°C), median (IQR) 37.9 (37.2 – 38.3) 37.5 (37.1 – 38.3) 0.578
High fever (≥39.0°C), n (%) 2 (12) 25 (15) 0.751
Saturation (%), median (IQR) 92 (87 – 96) 97 (94 – 98) 0.006
Low saturation (≤90%), n (%) 7 (44) 18 (12) 0.003
Throat redness, n (%) 2 (12) 35 (20) 0.534
Lung auscultatory findings, n (%) 12 (71) 54 (31) 0.002
Dyspnea, n (%) 6 (35) 39 (22) 0.369
Stupor, n (%) 1 (6) 2 (1.1) 0.245
Pneumonia on chest X-ray, n (%) 12 (71) 62 (39) 0.018
WBC (×10
3/ml
3), median (IQR) 7.4 (4.9 – 9.3) 7.8 (5.6 – 10.7) 0.611
% PNM (%), median (IQR) 85 (78 – 89) 78 (70 – 85) 0.010
PMN (×10
3/ml
3), median(IQR) 5.9 (4.2 – 8.1) 5.6 (3.9 – 8.7) 0.750
% LYM (%), median(IQR) 8 (6 – 14) 12 (7 – 19) 0.087
LYM (×10
3/ml
3), median(IQR) 0.6 (0.4 – 1.1) 0.9 (0.6 – 1.3) 0.057
Platelets (×10
3/ml
3), median (IQR) 203 (155 – 222) 209 (169 – 251) 0.307
Creatinine (mg/dl), median (IQR) 1.1 (0.9 – 1.4) 1.1 (0.9 – 1.3) 0.603
Bilirubin (mg/dl), median (IQR) 0.5 (0.3 – 0.7) 0.5 (0.3 – 0.7) 0.882
Alkaline phosphatase (U/l), median (IQR) 62 (47 – 91) 55 (4 – 76) 0.347
ALT (mg/dl), median (IQR) 28 (18 – 47) 25 (17 – 34) 0.373
GGT (mg/dl), median (IQR) 29 (10 – 47) 30 (15 – 39) 0.863
CRP (mg/L), median (IQR) 123 (69 – 184) 40 (20 – 82) <0.001
*Time from symptom onset until arrival to the ED.
ED, emergency department; ICU, intensive care unit; Sys, systolic; Dias, diastolic; IQR, interquartile range; WBC, white blood cells; PMN, polymorphonuclears; Lym,
lymphocytes; ALT, alanine aminotransferase; GGT, gamma-glutamyl transpeptidase; CRP, C-reactive protein.
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Page 4 of 8Figure 1 Box-plot of serum C-reactive protein levels on admission in patients who required admission to an intensive care unit
compared to those who did not. The dotted boxes represent the interquartile range (25th to 75th percentiles), the thick black line in the box is
the 50th percentile (median), and the bars represent the range of results, excluding outliers. The black dots are “outliers” and the black star is an
“extreme outlier”.
Figure 2 Box-plot of serum C-reactive protein levels on admission in patients who required mechanical ventilation compared to those
who did not. The dotted boxes represent the interquartile range (25th to 75th percentiles), the thick black line in the box is the 50th percentile
(median), and the bars represent the range of results, excluding outliers. The black dots are “outliers” and the black star is an “extreme outlier”.
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some of the patients in our series are usually found
among patients with bacterial infections [3-6]. Two ser-
ies of studies of lung specimens taken from autopsies of
patients who died in the recent pandemic reported that
many of the victims had a proven secondary bacterial
infection. Gill et al. [14] found histologic and microbio-
logic evidence of bacterial pneumonia in 55% of 34 peo-
ple who died following a confirmed pandemic influenza
A H1N1 virus infection. Similar findings were found in
29% of lung specimens from 77 fatal cases in another
series [15]. Thus, it is plausible that the high CRP levels
among some of the patients in the current study may
represent a secondary bacterial infection. Another possi-
ble explanation is that the high serum CRP levels repre-
sent a severe inflammatory response to the H1N1 virus.
A similar hypothesis was suggested with regards to
SARS, which was caused by the Corona virus in the
2002 outbreak. It was postulated that exaggerated acti-
vation of cytokines/chemokines played an significant
role in the pathogenesis of the disease leading to an
adverse outcome [16,17]. Either one of the aforemen-
tioned explanations is compatible with the current find-
ings, which indicate that CRP levels may serve as a
useful biomarker for predicting disease severity among
patients with suspected or confirmed H1N1 influenza
A virus infection.
One of the major limitations of the current work is its
retrospective nature and the relatively small number of
patients with a severe outcome. The absence of an
agreed protocol for the measurement of serum CRP in
patients with H1N1 virus infection admitted to the ED
led to the exclusion of 34% of the 315 patients from the
study cohort and may have also biased the results. Thus,
Table 2 ROC curve analysis describing the sensitivity,
specificity, negative-and positive-predictive values for
ICU admission and mechanical ventilation at different
cut-off levels
ICU
Serum CRP (mg/L) cut-off level Sensitivity Specificity PPV NPV
33 100 42 14 100
39 94 49 15 99
60 88 63 19 98
64 82 68 20 98
75 77 72 21 97
98 71 81 27 97
112 59 83 25 95
123 53 86 27 95
149 47 90 32 95
Mechanical ventilation
Serum CRP (mg/L) cut-off level Sensitivity Specificity PPV NPV
33 100 40 7 100
39 88 46 7 99
64 75 65 9 98
102 63 79 11 98
123 50 84 12 98
164 38 91 16 97
PPV, positive predictive value, NPV, negative predictive value.
Figure 3 Kaplan Meier analysis displaying the cumulative probability of not reaching the outcome measure of intensive care unit
admission for patients according to tertiles of serum CRP levels on admission to the emergency department. The blue line represents
<28 mg/L, the red line 28-69 mg/L, and the green line ≥70 mg/L.
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Page 6 of 8it may make it difficult to extrapolate the results to
another population. Despite these limitations, the asso-
ciation between CRP levels upon presentation to the ED
and patient outcome was significant and substantial.
Another potential limitation is the need for ICU care as
a measurement of outcome severity, since the decision
itself might have been based on, among other factors,
admission serum CRP levels. Only one patient in this
series was admitted to the ICU directly from the ED.
Conclusions
In the current sample of patients with pandemic H1N1
influenza A infection, the serum CRP levels obtained
during the first 24 hours since presentation to the ED
were found to be significantly correlated with impending
disease severity. Based on this finding, it is plausible that
this measurement may serve as a useful early biomarker
to identify patients at high risk for a complicated clinical
course of the disease. The ability to differentiate
between high and low risk patients has clear-cut clinical
and therapeutic implications for decision-making on
issues of patient management.
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